Daniel Goodman, PhD, is a synthetic biologist and immunologist working on high-throughput design and testing of genetically-engineered immune cell therapies. Daniel received his PhD in Medical Engineering and Physics from MIT, and has over 15 years of experience developing high-throughput experimental and computational methods to design, synthesize, and measure genetic systems. Daniel has authored over 20 scientific papers. His current work, at the University of California, San Francisco, involves multiplexed computationally-guided design of synthetic immune receptors to improve the efficacy of cell therapies.